A Novel Combined Nomogram Model for Predicting the Pathological Complete Response to Neoadjuvant Chemotherapy in Invasive Breast Carcinoma of No Specific Type: Real-World Study

被引:1
|
作者
Zhu, Xuelin [1 ,2 ,3 ]
Shen, Jing [1 ,2 ]
Zhang, Huanlei [4 ]
Wang, Xiulin [2 ,5 ]
Zhang, Huihui [2 ]
Yu, Jing [2 ]
Zhang, Qing [2 ]
Song, Dongdong [2 ]
Guo, Liping [6 ]
Zhang, Dianlong [7 ]
Zhu, Ruiping [8 ]
Wu, Jianlin [2 ]
机构
[1] Tianjin Med Univ, Grad Sch, Tianjin, Peoples R China
[2] Dalian Univ, Affiliated Zhongshan Hosp, Dept Radiol, Dalian, Peoples R China
[3] Qingzhou Peoples Hosp, Dept Ultrasound, Weifang, Peoples R China
[4] Yidu Cent Hosp Weifang, Dept Radiol, Weifang, Peoples R China
[5] Dalian Univ Technol, Fac Elect Informat & Elect Engn, Sch Biomed Engn, Dalian, Peoples R China
[6] Dalian Univ, Affiliated Zhongshan Hosp, Dept Ultrasound, Dalian, Peoples R China
[7] Dalian Univ, Affiliated Zhongshan Hosp, Dept Breast & Thyroid Surg, Dalian, Peoples R China
[8] Dalian Univ, Affiliated Zhongshan Hosp, Dept Pathol, Dalian, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2022年 / 12卷
关键词
multiparametric MRI; radiomics; neoadjuvant chemotherapy; invasive breast carcinoma of no specific type; pathologic complete response; MRI; STAGE;
D O I
10.3389/fonc.2022.916526
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
ObjectiveTo explore the value of a predictive model combining the multiparametric magnetic resonance imaging (mpMRI) radiomics score (RAD-score), clinicopathologic features, and morphologic features for the pathological complete response (pCR) to neoadjuvant chemotherapy (NAC) in invasive breast carcinoma of no specific type (IBC-NST). MethodsWe enrolled, retrospectively and consecutively, 206 women with IBC-NST who underwent surgery after NAC and obtained pathological results from August 2018 to October 2021. Four RAD-scores were constructed for predicting the pCR based on fat-suppression T2-weighted imaging (FS-T2WI), diffusion-weighted imaging (DWI), contrast-enhanced T1-weighted imaging (T1WI+C) and their combination, which was called mpMRI. The best RAD-score was combined with clinicopathologic and morphologic features to establish a nomogram model through binary logistic regression. The predictive performance of the nomogram was evaluated using the area under receiver operator characteristic (ROC) curve (AUC) and calibration curve. The clinical net benefit of the model was evaluated using decision curve analysis (DCA). ResultsThe mpMRI RAD-score had the highest diagnostic performance, with AUC of 0.848 among the four RAD-scores. T stage, human epidermal growth factor receptor-2 (HER2) status, RAD-score, and roundness were independent factors for predicting the pCR (P < 0.05 for all). The combined nomogram model based on these factors achieved AUCs of 0.930 and 0.895 in the training cohort and validation cohort, respectively, higher than other models (P < 0.05 for all). The calibration curve showed that the predicted probabilities of the nomogram were in good agreement with the actual probabilities, and DCA indicated that it provided more net benefit than the treat-none or treat-all scheme by decision curve analysis in both training and validation datasets. ConclusionThe combined nomogram model based on the mpMRI RAD-score combined with clinicopathologic and morphologic features may improve the predictive performance for the pCR of NAC in patients with IBC-NST.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] A real-world clinicopathological model for predicting pathological complete response to neoadjuvant chemotherapy in breast cancer
    Fang, Shan
    Xia, Wenjie
    Zhang, Haibo
    Ni, Chao
    Wu, Jun
    Mo, Qiuping
    Jiang, Mengjie
    Guan, Dandan
    Yuan, Hongjun
    Chen, Wuzhen
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [2] Real-world Factors Predicting Complete Pathological Response to Neoadjuvant Chemotherapy in Breast Cancer
    Rubasingham, J.
    Loo, V.
    CLINICAL ONCOLOGY, 2019, 31 (07) : E113 - E114
  • [3] Factors predicting complete pathological response to neoadjuvant chemotherapy in breast carcinoma
    Belhadj, O.
    Boudaouara, O.
    Ben Makhlouf, W.
    Triki, M.
    Zghal, M.
    Ayadi, L.
    Boudawara, T. Sellami
    Ben Kridis, W.
    VIRCHOWS ARCHIV, 2024, 485 : S188 - S188
  • [4] Predicting pathological complete response in the axilla post neoadjuvant chemotherapy in carcinoma breast
    AbduRahman, A.
    Kumar, S. R.
    Oomen, A.
    Binesh, P.
    BREAST, 2021, 56 : S55 - S55
  • [5] Development of a nomogram for predicting pathological complete response in luminal breast cancer patients following neoadjuvant chemotherapy
    Garufi, Giovanna
    Carbognin, Luisa
    Sperduti, Isabella
    Miglietta, Federica
    Dieci, Maria Vittoria
    Mazzeo, Roberta
    Orlandi, Armando
    Gerratana, Lorenzo
    Palazzo, Antonella
    Fabi, Alessandra
    Paris, Ida
    Franco, Antonio
    Franceschini, Gianluca
    Fiorio, Elena
    Pilotto, Sara
    Guarneri, Valentina
    Puglisi, Fabio
    Conte, Pierfranco
    Milella, Michele
    Scambia, Giovanni
    Tortora, Giampaolo
    Bria, Emilio
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2023, 15
  • [6] Predicting pathological complete response after neoadjuvant chemotherapy: A nomogram combining clinical features and ultrasound semantics in patients with invasive breast cancer
    Wang, Ke-Nie
    Meng, Ya-Jiao
    Yu, Yue
    Cai, Wen-Run
    Wang, Xin
    Cao, Xu-Chen
    Ge, Jie
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [7] Individualized model for predicting pathological complete response to neoadjuvant chemotherapy in patients with breast cancer: A multicenter study
    Qian, Bei
    Yang, Jing
    Zhou, Jun
    Hu, Longqing
    Zhang, Shoupeng
    Ren, Min
    Qu, Xincai
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [8] Biomarkers Predicting Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer
    Li, Xiaoxian
    Krishnamurti, Uma
    Bhattarai, Shristi
    Klimov, Sergey
    Reid, Michelle
    Aneja, Ritu
    LABORATORY INVESTIGATION, 2016, 96 : 54A - 54A
  • [9] Biomarkers Predicting Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer
    Li, Xiaoxian
    Krishnamurti, Uma
    Bhattarai, Shristi
    Klimov, Sergey
    Reid, Michelle
    Aneja, Ritu
    MODERN PATHOLOGY, 2016, 29 : 54A - 54A
  • [10] Nomogram for predicting pathological complete response to neoadjuvant chemotherapy in patients with advanced gastric cancer
    Chen, Yong-He
    Xiao, Jian
    Chen, Xi-Jie
    Wang, Hua-She
    Liu, Dan
    Xiang, Jun
    Peng, Jun-Sheng
    WORLD JOURNAL OF GASTROENTEROLOGY, 2020, 26 (19) : 2427 - 2439